Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 159861 | Syrma SGS Technology Ltd (SYRMA.NS) | XNSE | IN | 2023-03-31 | 1 day ago | INR | 487.90 | 95.20 | 19.51% | 12.76 | 2.61% | NCAV (Net-Net) | 12.76 | 2.61% |
| 159862 | Syros Pharmaceuticals Inc (0LC7.L) | XLON | US | 2023-12-31 | 1 day ago | USD | 5.07 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 159863 | Syros Pharmaceuticals Inc (0S9.BE) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.63 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 159864 | Syros Pharmaceuticals Inc (0S9.DU) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.63 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 159865 | Syros Pharmaceuticals Inc (0S9.F) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.63 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 159866 | Syros Pharmaceuticals Inc (0S9.MU) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.63 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 159867 | Syros Pharmaceuticals Inc (0S9.SG) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.63 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 159868 | Syros Pharmaceuticals Inc (0S9.TG) | XGAT | US | 2023-12-31 | 2 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 159869 | Syros Pharmaceuticals Inc (0S90.BE) | XBER | US | 2023-12-31 | 1 day ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 159870 | Syros Pharmaceuticals Inc (0S90.DU) | XDUS | US | 2023-12-31 | 2 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |